Lack of correlation between the number of circulating B cells and the concentration of serum antibodies reactive with the HIV-1 envelope glycoprotein

J Acquir Immune Defic Syndr (1988). 1994 May;7(5):447-53.

Abstract

Cells obtained from the peripheral blood of HIV-infected patients and volunteers immunized with HIV-1 vaccines are commonly used to study anti-viral responses, since lymphocytes from the central lymphoid organs are difficult to obtain. Analyses involving PBMC implicitly assume that circulating B cells provide an accurate reflection of the systemic humoral response induced by the HIV antigens. We examined this assumption by comparing the number of B cells secreting IgG anti-gp160/120 antibodies in the peripheral circulation with serum antibody titers. Results indicate that neither the magnitude nor duration of the serologic response detected in HIV-infected patients or gp160/gp120-immunized volunteers reproducibly correlates with the number of B cells secreting anti-envelope antibodies in the blood.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS Vaccines / immunology*
  • Adult
  • B-Lymphocytes / immunology*
  • Female
  • Gene Products, env / immunology
  • HIV Antibodies / blood*
  • HIV Envelope Protein gp120 / immunology
  • HIV Envelope Protein gp160
  • HIV Infections / immunology*
  • HIV-1 / immunology*
  • Humans
  • Immunization, Secondary
  • Immunoglobulin G / blood
  • Lymphocyte Activation
  • Male
  • Protein Precursors / immunology
  • Recombinant Proteins / immunology
  • Vaccines, Synthetic / immunology

Substances

  • AIDS Vaccines
  • Gene Products, env
  • HIV Antibodies
  • HIV Envelope Protein gp120
  • HIV Envelope Protein gp160
  • HIVAC-1e
  • Immunoglobulin G
  • Protein Precursors
  • Recombinant Proteins
  • Vaccines, Synthetic
  • VaxSyn HIV-1 (gp160) vaccine